Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0941820060160020101
Korean Journal of Clinical Pharmacy
2006 Volume.16 No. 2 p.101 ~ p.106
Bioequivalence Study on Two Talniflumate Preparations Commercially Available in Korean
Sohn Uy-Dong

Je Hyun-Dong
Shin Yong-Kyoo
Min Young-Sil
Jeong Ji-Hoon
Kim Kyung-Tae
Cho Young-Rae
Song Hyun-Ju
Cho Seong-Wan
Yim Sung-Hyuk
Abstract
The aim of the present study was to evaluate the bioequivalence of two talniflumate preparations. We used Somalgen tablet (Kun Wha Pharmaceutical Co., Korea.) as a reference drug for bioequivalence of Crimain tablet (Samjini Pharmaceutical Ind. Co., Korea), and performed this whole study according to the guidelines of Korea Food and Drug Administraion(KFDA). Twenty four healthy male volunteers, 22.8¡¾2.2 years in age and 64.6¡¾5.3 kg in body weight, were divided into two groups and a randomized 2X2 cross-over study was employed. After one tablet containing 370mg of talniflumate was orally administered, blood was taken at predetermined time intervals and the concentrations of taliflumate in plasma were determined using HPLC method with UV-detector. The analysis system was validated in specificity, accuracy, precision and linearity. These items of the analysis condition in this study conform to the guideline of KFDA. The pharmacokinetic parameters such as AUCt and Cmax were calculated using the analysis condition we established and ANOVA test was utilized for the statistical analysis of the parameters using logarithmically transformed AUCt and Cmax. Mean¡¾SD of reference drug and test drug in AUCt and Cmax value were 1.27¡¾0.58 (¥ìg/ml*hr) and 0.27¡¾0.13(¥ìg/ml) and 1.14¡¾0.46(¥ìg/ml*hr) and 0.26¡¾0.10(¥ìg/ml) respectively. The 90% confidence intervals using logarithmically transformed data were within the acceptance range of log(0.8) to log(1.25) for AUCt and Cmax, respectively. These results indicate that Samjin talniflumate tablet is bioequivalent to reference drug, Somalgen tablet.
KEYWORD
Talniflumate, Bioequivalence, HPLC
FullTexts / Linksout information
Listed journal information
ÇмúÁøÈïÀç´Ü(KCI)